Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
5519
Units (stock acquisition rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options (TERUMO CORPORATION 14th Series Share Acquisition Rights)
発行・処分する株式数
44,152 ordinary shares (5,519 share acquisition rights × 8 shares per right; the total number of shares issued will decrease if the number of rights scheduled to be allotted decreases)
Intended allottee
Name The Company's executive officers / Number of Employees 11 / Number of stock acquisition rights 4,754 share acquisition rights, Name The Company's officers in charge / Number of Employees 1 / Number of stock acquisition rights 255 rights, Name The Company's fellows / Number of Employees 2 / Number of stock acquisition rights 510 share acquisition rights
Terms of the stock acquisition rights
Exercise price
¥1 per share. Adjustment provisions are Not disclosed (fixed exercise price)
Exercise period
Start Date 5 August 2026 / End date 4 August 2056
Number of Stock Acquisition Rights
Total number issued 5,519 share acquisition rights (number scheduled to be allotted; this may decrease if applications are not submitted, among other circumstances) / Number of unexercised units Not disclosed
Reason for acquisition without consideration
The Company may acquire the share acquisition rights without consideration if a proposal concerning a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions, or the establishment of an acquisition provision for the class shares subject to the rights is approved at a shareholders meeting. If a shareholders meeting resolution is not required, the same applies when the proposal is approved by a resolution of the Board of Directors.
Categories and Number of Persons Covered
Category The Company's executive officers / Number of Employees 11 / Number of allocated stock acquisition rights 4,754 share acquisition rights, Category The Company's officers in charge / Number of Employees 1 / Number of allocated stock acquisition rights 255 rights, Category The Company's fellows / Number of Employees 2 / Number of allocated stock acquisition rights 510 share acquisition rights
Payment date
4 August 2026
Basis for determining the amount to be paid
The payment amount for the share acquisition rights will be calculated using the Black-Scholes model. The share price will be the closing price for ordinary transactions on the Tokyo Stock Exchange on 4 August 2026, and the expected remaining term will be 5.6 years. Volatility will be based on closing prices from 4 January 2021 to 4 August 2026. The discount rate and premium rate are Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options (TERUMO CORPORATION 14th Series Share Acquisition Rights) |
| Number of shares to be issued or disposed of | 44,152 ordinary shares (5,519 share acquisition rights × 8 shares per right; the total number of shares issued will decrease if the number of rights scheduled to be allotted decreases) |
| Payment date | 4 August 2026 |
| Intended allottee | Name The Company's executive officers / Number of Employees 11 / Number of stock acquisition rights 4,754 share acquisition rights, Name The Company's officers in charge / Number of Employees 1 / Number of stock acquisition rights 255 rights, Name The Company's fellows / Number of Employees 2 / Number of stock acquisition rights 510 share acquisition rights |
| Basis for determining the amount to be paid | The payment amount for the share acquisition rights will be calculated using the Black-Scholes model. The share price will be the closing price for ordinary transactions on the Tokyo Stock Exchange on 4 August 2026, and the expected remaining term will be 5.6 years. Volatility will be based on closing prices from 4 January 2021 to 4 August 2026. The discount rate and premium rate are Not disclosed. |
| Exercise price | ¥1 per share. Adjustment provisions are Not disclosed (fixed exercise price) |
| Exercise period | Start Date 5 August 2026 / End date 4 August 2056 |
| Number of Stock Acquisition Rights | Total number issued 5,519 share acquisition rights (number scheduled to be allotted; this may decrease if applications are not submitted, among other circumstances) / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | The Company may acquire the share acquisition rights without consideration if a proposal concerning a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions, or the establishment of an acquisition provision for the class shares subject to the rights is approved at a shareholders meeting. If a shareholders meeting resolution is not required, the same applies when the proposal is approved by a resolution of the Board of Directors. |
| Categories and Number of Persons Covered | Category The Company's executive officers / Number of Employees 11 / Number of allocated stock acquisition rights 4,754 share acquisition rights, Category The Company's officers in charge / Number of Employees 1 / Number of allocated stock acquisition rights 255 rights, Category The Company's fellows / Number of Employees 2 / Number of allocated stock acquisition rights 510 share acquisition rights |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enable executive officers, officers in charge and fellows to fulfill their roles and responsibilities while sharing value with shareholders, and to further encourage them to contribute to share price appreciation and the enhancement of corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.